Concepedia

Publication | Open Access

Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study

DOIFull Paper Access

20

Citations

6

References

2017

Year

Soon Wai Ch’ng, Alexander J. Brent, Theodoros Empeslidis, Vasileios Konidaris, Somnath Banerjee
Ophthalmology and Therapy

Abstract

The use of Iluvien in refractory DME patients represents a cost- and time-saving procedure, while showing non-inferiority in terms of efficacy.

References

YearCitations

Page 1